SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Chamorro J) "

Sökning: WFRF:(Chamorro J)

  • Resultat 1-30 av 30
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Ederle, Joerg, et al. (författare)
  • Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
  • 2010
  • Ingår i: The Lancet. - 1474-547X. ; 375:9719, s. 985-997
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Stents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis, but previous trials have not established equivalent safety and efficacy. We compared the safety of carotid artery stenting with that of carotid endarterectomy. Methods The International Carotid Stenting Study (ICSS) is a multicentre, international, randomised controlled trial with blinded adjudication of outcomes. Patients with recently symptomatic carotid artery stenosis were randomly assigned in a 1:1 ratio to receive carotid artery stenting or carotid endarterectomy. Randomisation was by telephone call or fax to a central computerised service and was stratified by centre with minimisation for sex, age, contralateral occlusion, and side of the randomised artery. Patients and investigators were not masked to treatment assignment. Patients were followed up by independent clinicians not directly involved in delivering the randomised treatment. The primary outcome measure of the trial is the 3-year rate of fatal or disabling stroke in any territory, which has not been analysed yet. The main outcome measure for the interim safety analysis was the 120-day rate of stroke, death, or procedural myocardial infarction. Analysis was by intention to treat (ITT). This study is registered, number ISRCTN25337470. Findings The trial enrolled 1713 patients (stenting group, n=855; endarterectomy group, n=858). Two patients in the stenting group and one in the endarterectomy group withdrew immediately after randomisation, and were not included in the ITT analysis. Between randomisation and 120 days, there were 34 (Kaplan-Meier estimate 4.0%) events of disabling stroke or death in the stenting group compared with 27 (3.2%) events in the endarterectomy group (hazard ratio [HR] 1.28, 95% CI 0.77-2.11). The incidence of stroke, death, or procedural myocardial infarction was 8.5% in the stenting group compared with 5.2% in the endarterectomy group (72 vs 44 events; HR 1.69, 1.16-2.45, p=0.006), Risks of any stroke (65 vs 35 events; HR 1.92, 1.27-2.89) and all-cause death (19 vs seven events; HR 2.76, 1.16-6.56) were higher in the stenting group than in the endarterectomy group. Three procedural myocardial infarctions were recorded in the stenting group, all of which were fatal, compared with four, all non-fatal, in the endarterectomy group. There was one event of cranial nerve palsy in the stenting group compared with 45 in the endarterectomy group. There were also fewer haematomas of any severity in the stenting group than in the endarterectomy group (31 vs 50 events; p=0.0197). Interpretation Completion of long-term follow-up is needed to establish the efficacy of carotid artery stenting compared with endarterectomy. In the meantime, carotid endarterectomy should remain the treatment of choice for patients suitable for surgery.
  •  
2.
  •  
3.
  •  
4.
  • Ringleb, PA, et al. (författare)
  • Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
  • 2008
  • Ingår i: Cerebrovascular diseases (Basel, Switzerland). - : S. Karger AG. - 1421-9786 .- 1015-9770. ; 25:5, s. 457-507
  • Tidskriftsartikel (refereegranskat)abstract
    • This article represents the update of the European Stroke Initiative Recommendations for Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic attacks, which are now considered to be a single entity. The article covers referral and emergency management, Stroke Unit service, diagnostics, primary and secondary prevention, general stroke treatment, specific treatment including acute management, management of complications, and rehabilitation.
  •  
5.
  • Astell, A. J., et al. (författare)
  • Developing a pragmatic evaluation of ICTs for older adults with cognitive impairment at scale : the IN LIFE experience
  • 2022
  • Ingår i: Universal Access in the Information Society. - Heidelberg, Germany : Springer. - 1615-5289 .- 1615-5297. ; 21:1, s. 1-19
  • Tidskriftsartikel (refereegranskat)abstract
    • Implementing information and communications technology (ICT) at scale requires evaluation processes to capture the impacton users as well as the infrastructure into which it is being introduced. For older adults living with cognitive impairment, thisrequires evaluation that can accommodate diferent levels of cognitive impairment, alongside input from family and formalcaregivers, plus stakeholder organisations. The European Horizon 2020 project INdependent LIving support Functions forthe Elderly (IN LIFE) set out to integrate 17 technologies into a single digital platform for older people living with cognitive impairment plus their families, care providers and stakeholders. The IN LIFE evaluation took place across six nationalpilot sites to examine a number of variables including impact on the users, user acceptance of the individual services andthe overall platform, plus the economic case for the IN LIFE platform. The results confrmed the interest and need amongolder adults, family caregivers, formal caregivers and stakeholders, for information and communications technology (ICT).Relative to the baseline, quality of life improved and cognition stabilised; however, there was an overall reluctance to payfor the platform. The fndings provide insights into existing barriers and challenges for adoption of ICT for older peopleliving with cognitive impairment.
  •  
6.
  • Astell, A. J., et al. (författare)
  • Developing a pragmatic evaluation of ICTs for older adults with cognitive impairment at scale: the IN LIFE experience
  • 2021
  • Ingår i: Universal Access in the Information Society. - Heidelberg, Germany : Springer. - 1615-5289 .- 1615-5297.
  • Tidskriftsartikel (refereegranskat)abstract
    • Implementing information and communications technology (ICT) at scale requires evaluation processes to capture the impact on users as well as the infrastructure into which it is being introduced. For older adults living with cognitive impairment, this requires evaluation that can accommodate different levels of cognitive impairment, alongside input from family and formal caregivers, plus stakeholder organisations. The European Horizon 2020 project INdependent LIving support Functions for the Elderly (IN LIFE) set out to integrate 17 technologies into a single digital platform for older people living with cognitive impairment plus their families, care providers and stakeholders. The IN LIFE evaluation took place across six national pilot sites to examine a number of variables including impact on the users, user acceptance of the individual services and the overall platform, plus the economic case for the IN LIFE platform. The results confirmed the interest and need among older adults, family caregivers, formal caregivers and stakeholders, for information and communications technology (ICT). Relative to the baseline, quality of life improved and cognition stabilised; however, there was an overall reluctance to pay for the platform. The findings provide insights into existing barriers and challenges for adoption of ICT for older people living with cognitive impairment.
  •  
7.
  • Mikulik, R., et al. (författare)
  • Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source NAVIGATE-ESUS Trial
  • 2020
  • Ingår i: Stroke. - : Ovid Technologies (Wolters Kluwer Health). - 0039-2499 .- 1524-4628. ; 51:7, s. 2139-2147
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and Purpose: Risks, sites, and predictors of major bleeding during antithrombotic therapies have not been well defined for patients with recent embolic stroke of undetermined source. Methods: Exploratory analysis of major bleeds defined by International Society of Thrombosis and Hemostasis criteria occurring among 7213 participants in international NAVIGATE (New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial) embolic stroke of undetermined source randomized trial comparing rivaroxaban 15 mg daily with aspirin 100 mg daily. Results: During a median follow-up of 11 months, 85 major bleeds occurred. The most frequent site was gastrointestinal (38%), followed by intracranial (29%). Assignment to rivaroxaban (hazard ratio [HR], 2.7 [95% CI, 1.7-4.3]), East Asia region (HR, 2.5 [95% CI, 1.6-3.9]), systolic blood pressure >= 160 mm Hg (HR, 2.2 [95% CI, 1.2-3.8]), and reduced estimated glomerular filtration rate (HR, 1.2 per 10 mL/min per 1.73 m(2)decrease, [95% CI, 1.0-1.3]) were independently associated with presence of major bleeds. Five (6%) were fatal. Among 15 patients with intracerebral hemorrhage, 2 (13%) were fatal. There was no evidence of an early high-risk period following initiation of rivaroxaban. The annualized rate of intracerebral hemorrhage was 6-fold higher among East Asian participants (0.67%) versus all other regions (0.11%; HR, 6.3 [95% CI, 2.2-18.0]). Distribution of bleeding sites was similar for rivaroxaban and aspirin. Conclusions: Among embolic stroke of undetermined source patients participating in an international randomized trial, independent predictors of major bleeding were assignment to rivaroxaban, East Asia region, increased systolic blood pressure, and impaired renal function. East Asia as a region was strongly associated with risk of intracerebral hemorrhage. Estimated glomerular filtration rate should be a consideration for stratifying bleeding risk. Registration: URL:. Unique identifier: NCT02313909.
  •  
8.
  •  
9.
  •  
10.
  •  
11.
  • Martinez-Majander, N., et al. (författare)
  • Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial
  • 2020
  • Ingår i: European Journal of Neurology. - : Wiley. - 1351-5101 .- 1468-1331. ; 27:5, s. 841-848
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and purpose Cancer is a frequent finding in ischaemic stroke patients. The frequency of cancer amongst participants in the NAVIGATE ESUS randomized trial and the distribution of outcome events during treatment with aspirin and rivaroxaban were investigated. Methods Trial participation required a recent embolic stroke of undetermined source. Patients' history of cancer was recorded at the time of study entry. During a mean follow-up of 11 months, the effects of aspirin and rivaroxaban treatment on recurrent ischaemic stroke, major bleeding and all-cause mortality were compared between patients with cancer and patients without cancer. Results Amongst 7213 randomized patients, 543 (7.5%) had cancer. Of all patients, 3609 were randomized to rivaroxaban [254 (7.0%) with cancer] and 3604 patients to aspirin [289 (8.0%) with cancer]. The annual rate of recurrent ischaemic stroke was 4.5% in non-cancer patients in the rivaroxaban arm and 4.6% in the aspirin arm [hazard ratio (HR) 0.98, 95% confidence interval (CI) 0.78-1.24]. In cancer patients, the rate of recurrent ischaemic stroke was 7.7% in the rivaroxaban arm and 5.4% in the aspirin arm (HR 1.43, 95% CI 0.71-2.87). Amongst cancer patients, the annual rate of major bleeds was non-significantly higher for rivaroxaban than aspirin (2.9% vs. 1.1%; HR 2.57, 95% CI 0.67-9.96; P for interaction 0.95). All-cause mortality was similar in both groups. Conclusions Our exploratory analyses show that patients with embolic stroke of undetermined source and a history of cancer had similar rates of recurrent ischaemic strokes and all-cause mortality during aspirin and rivaroxaban treatments and that aspirin appeared safer than rivaroxaban in cancer patients regarding major bleeds. (NCT02313909).
  •  
12.
  • Marto, João Pedro, et al. (författare)
  • Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.
  • 2023
  • Ingår i: Neurology. - 1526-632X. ; 100:7
  • Tidskriftsartikel (refereegranskat)abstract
    • COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.This was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT).Of a total of 15,128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19; of those, 5,848 (38.7%) patients received IVT-only and 9,280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted OR 1.53; 95% CI 1.16-2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20-2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23-1.99), 24-hour mortality (OR 2.47; 95% CI 1.58-3.86), and 3-month mortality (OR 1.88; 95% CI 1.52-2.33). Patients with COVID-19 also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26-1.60).Patients with AIS and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 patients receiving treatment. Current available data do not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in patients with COVID-19 or to establish different treatment recommendations in this subgroup of patients with ischemic stroke. Our findings can be taken into consideration for treatment decisions, patient monitoring, and establishing prognosis.The study was registered under ClinicalTrials.gov identifier NCT04895462.
  •  
13.
  •  
14.
  • Veltkamp, R., et al. (författare)
  • Characteristics of Recurrent Ischemic Stroke after Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial
  • 2020
  • Ingår i: JAMA Neurology. - : American Medical Association (AMA). - 2168-6149. ; 77:10, s. 1233-1240
  • Tidskriftsartikel (refereegranskat)abstract
    • Importance: The concept of embolic stroke of undetermined source (ESUS) unifies a subgroup of cryptogenic strokes based on neuroimaging, a defined minimum set of diagnostic tests, and exclusion of certain causes. Despite an annual stroke recurrence rate of 5%, little is known about the etiology underlying recurrent stroke after ESUS. Objective: To identify the stroke subtype of recurrent ischemic strokes after ESUS, to explore the interaction with treatment assignment in each category, and to examine the consistency of cerebral location of qualifying ESUS and recurrent ischemic stroke. Design, Setting, and Participants: The NAVIGATE-ESUS trial was a randomized clinical trial conducted from December 23, 2014, to October 5, 2017. The trial compared the efficacy and safety of rivaroxaban and aspirin in patients with recent ESUS (n = 7213). Ischemic stroke was validated in 309 of the 7213 patients by adjudicators blinded to treatment assignment and classified by local investigators into the categories ESUS or non-ESUS (ie, cardioembolic, atherosclerotic, lacunar, other determined cause, or insufficient testing). Five patients with recurrent strokes that could not be defined as ischemic or hemorrhagic in absence of neuroimaging or autopsy were excluded. Data for this secondary post hoc analysis were analyzed from March to June 2019. Interventions: Patients were randomly assigned to receive rivaroxaban, 15 mg/d, or aspirin, 100 mg/d. Main Outcomes and Measures: Association of recurrent ESUS with stroke characteristics. Results: A total of 309 patients (205 men [66%]; mean [SD] age, 68 [10] years) had ischemic stroke identified during the median follow-up of 11 (interquartile range [IQR], 12) months (annualized rate, 4.6%). Diagnostic testing was insufficient for etiological classification in 39 patients (13%). Of 270 classifiable ischemic strokes, 156 (58%) were ESUS and 114 (42%) were non-ESUS (37 [32%] cardioembolic, 26 [23%] atherosclerotic, 35 [31%] lacunar, and 16 [14%] other determined cause). Atrial fibrillation was found in 27 patients (9%) with recurrent ischemic stroke and was associated with higher morbidity (median change in modified Rankin scale score 2 [IQR, 3] vs 0 (IQR, 1]) and mortality (15% vs 1%) than other causes. Risk of recurrence did not differ significantly by subtype between treatment groups. For both the qualifying and recurrent strokes, location of infarct was more often in the left (46% and 54%, respectively) than right hemisphere (40% and 37%, respectively) or brainstem or cerebellum (14% and 9%, respectively). Conclusions and Relevance: In this secondary analysis of randomized clinical trial data, most recurrent strokes after ESUS were embolic and of undetermined source. Recurrences associated with atrial fibrillation were a minority but were more often disabling and fatal. More extensive investigation to identify the embolic source is important toward an effective antithrombotic strategy. Trial Registration: ClinicalTrials.gov Identifier: NCT02313909.. © 2020 American Medical Association. All rights reserved.
  •  
15.
  •  
16.
  •  
17.
  • Chamorro, CI, et al. (författare)
  • A database on differentially expressed microRNAs during rodent bladder healing
  • 2021
  • Ingår i: Scientific reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 11:1, s. 21881-
  • Tidskriftsartikel (refereegranskat)abstract
    • Urinary bladder wound healing relies on multiple biological events that are finely tuned in a spatial–temporal manner. MicroRNAs are small non-coding RNA molecules with regulatory functions. We hypothesized that microRNAs are important molecules in the coordination of normal urinary bladder wound healing. We aimed at identifying microRNAs expressed during bladder wound healing using Affymetrix global array for microRNA profiling of the rodent urinary bladder during healing of a surgically created wound. Results were validated in the rat bladders by real-time PCR (RT-PCR) using three of the differentially expressed (DE) microRNAs. The model was thereafter validated in human cells, by measuring the expression of eight of the DE microRNAs upon in vitro wound-healing assays in primary urothelial cells. Our results indicated that 508 (40%) of all rodent microRNAs were expressed in the urinary bladder during wound healing. Thirteen of these microRNAs (1%) were DE (false discovery rate (FDR) < 0.05, P < 0.05, |logfold|> 0.25) in wounded compared to non-wounded bladders. Bioinformatic analyses helped us to identify target molecules for the DE microRNAs, and biological pathways involved in tissue repair. All data are made available in an open-access database for other researchers to explore.
  •  
18.
  •  
19.
  • Chamorro Vera, Harold Rene, et al. (författare)
  • Coherency Estimation in Power Systems : A Koopman Operator Approach
  • 2019
  • Ingår i: Springer Optimization and Its Applications. - Cham : Springer International Publishing. - 9783030254452 - 9783030254469 ; , s. 201-225
  • Bokkapitel (refereegranskat)abstract
    • Integrating a significant amount of non-synchronous generation into power systems creates new technical challenges for transmission systems. The research and understanding of the impact of the non-synchronous generation through back-to-back Full Rated Converters’ (FRCs) on power system’s coherency is a matter of importance. Coherency behavior under the presence of large inclusion of non-synchronous generation requires more research, in order to understand the forming groups, after a disturbance, when the inertia is decreasing due to the decoupling. This document presents the application of the so-called Koopman Operator for the identification of coherent groups in power systems with the influence of non-synchronous generation. The Koopman Analysis clusters the coherent groups based on the measurements obtained. The visualization of the coherent groups identified allows to observe their dynamic variations according to the penetration level or fault location. The applied method of coherency identification is evaluated in the Nordic test system through gradually increasing integration of non-synchronous generations and different fault scenarios.
  •  
20.
  • Chamorro Vera, Harold R., et al. (författare)
  • On the Optimization of Damping Enhancement in a Power System with a Hybrid HVDC Link
  • 2019
  • Ingår i: Proceedings of 2019 IEEE PES Innovative Smart Grid Technologies Europe, ISGT-Europe 2019. - : Institute of Electrical and Electronics Engineers (IEEE).
  • Konferensbidrag (refereegranskat)abstract
    • Hybrid HVDC links incorporate both Line Commutated Converters (LCC) and Voltage Source Converters (VSC) systems, thereby gathering the benefits of both technologies. Supplementary Power Oscillation Damping (POD) controllers can be added to both LCCs and VSCs to help enhance the power system stability against disturbances, such as short circuits. However POD controller tuning can be a delicate process, due to the highly non-linear and complex nature of the involved power system, which might induce adverse interactions leading to a reduced damping. This paper proposes the application of the Simulated Annealing Algorithm (SAA) for tuning the POD controllers parameters, with the purpose of optimizing the performance of POD controllers in the power system. The damping performance is evaluated in case of multiple disturbances in a test power system. The results show the ability of the proposed technique to enhance the performance of the POD controllers under various operating conditions.
  •  
21.
  • Engberg, GR, et al. (författare)
  • Transplantation of autologous minced bladder mucosa for a one-step reconstruction of a tissue engineered bladder conduit
  • 2013
  • Ingår i: BioMed research international. - : Hindawi Limited. - 2314-6141 .- 2314-6133. ; 2013, s. 212734-
  • Tidskriftsartikel (refereegranskat)abstract
    • Surgical intervention is sometimes needed to create a conduit from the abdominal wall to the bladder for self-catheterization. We developed a method for tissue engineering a conduit for bladder emptying withoutin vitrocell culturing as a one-step procedure. In a porcine animal model bladder, wall tissue was excised and the mucosa was minced to small particles. The particles were attached to a tube in a 1 : 3 expansion rate with fibrin glue and transplanted back by attaching the tube to the bladder and through the abdominal wall. Sham served as controls. After 4-5 weeks, conduits were assessed in respect to macroscopic and microscopic appearance in 6 pigs. Two pigs underwent radiology before termination. Gross examination revealed a patent conduit with an opening to the bladder. Histology and immunostaining showed a multilayered transitional uroepithelium in all cases. Up to 89% of the luminal surface area was neoepithelialized but with a loose attachment to the submucosa. No epithelium was found in control animals. CT imaging revealed a patent channel that could be used for filling and emptying the bladder. Animals that experienced surgical complications did not form conduits. Minced autologous bladder mucosa can be transplanted around a tubular mold to create a conduit to the urinary bladder withoutin vitroculturing.
  •  
22.
  • Gutierrez, A., et al. (författare)
  • Hardware-in-the-loop simulation of PV systems in micro-grids using SysML models
  • 2015
  • Ingår i: 2015 IEEE 16th Workshop on Control and Modeling for Power Electronics. - : IEEE. - 9781467368476
  • Konferensbidrag (refereegranskat)abstract
    • This paper outlines a methodology for modeling photovoltaic systems in embedded hardware. This methodology uses the HiLeS platform to transform SysML models in Petri nets and generate VHDL code. The proposed methodology is intended for Hardware-in-the-Loop simulations of power converters and PV panels in microgrids. In addition, this methodology allows the design of MPPT controllers for their direct implementation in FPGA.
  •  
23.
  • Gutierrez, A., et al. (författare)
  • Supervisory Control for Interleaved Boost Converters using HiLeS-Designer
  • 2014
  • Ingår i: 2014 16TH EUROPEAN CONFERENCE ON POWER ELECTRONICS AND APPLICATIONS (EPE'14-ECCE EUROPE). - : IEEE Press.
  • Konferensbidrag (refereegranskat)abstract
    • This paper presents the application of HiLeS (High Level Specification of Embedded Systems) formalism to design a supervisory controller based on FPGA for interleaved boost converters. This controller is intended to increase the versatility and efficiency of interleaved boost converters. Furthermore, the proposed supervisory controller uses Petri nets for structural analysis and stability. HiLeS-Designer tool, which is a platform based on HiLeS formalism, is used to design and implement the supervisory controller in embedded hardware. This approach uses the digital component of VHDL-AMS code generated by the HiLeS-Designer tool to implement the supervisory controller in FPGA. Simulations and experimental results show that the proposed control strategy increases the operating range and efficiency of interleaved boost converters.
  •  
24.
  • Gutierrez, A., et al. (författare)
  • SysML Methodology for HIL Implementation of PV Models
  • 2015
  • Ingår i: 2015 17TH EUROPEAN CONFERENCE ON POWER ELECTRONICS AND APPLICATIONS (EPE'15 ECCE-EUROPE). - : IEEE. - 9789075815238
  • Konferensbidrag (refereegranskat)abstract
    • This paper describes a methodology for implementing in FPGA models of photovoltaic panels for Hardware-in-the-Loop (HIL) and real-time simulations. The proposed methodology integrates numerical solutions, SysML diagrams and Petri nets for structural design and formal validation. In this study, photovoltaic cells have been modeled using the single diode circuit. The photovoltaic panel model is solved by the Newton-Raphson method, and the Lagrange remainder is employed to limit the iteration number. Results show suitable accuracy and performance of the proposed methodology.
  •  
25.
  •  
26.
  • Mayorga, J. L., et al. (författare)
  • Development of real-time control emulator in FPGA using HiLeS methodology
  • 2015
  • Ingår i: IECON 2015 - 41st Annual Conference of the IEEE Industrial Electronics Society. - : Institute of Electrical and Electronics Engineers (IEEE). - 9781479917624 ; , s. 4076-4081
  • Konferensbidrag (refereegranskat)abstract
    • Embedded systems (ES) based on field programmable gate arrays (FPGAs) enhance the overall computational capability and relieve computational load. The lack on design and implementation methods for specific control functions in hardware limits the application of complex control techniques. Therefore, a design methodology approach is showed in the current work. Fuzzy, LQR, and PI control systems are modeled using HiLeS-RCP (High Level Specification of Embedded Systems-Rich Client Platform), a methodology that links the requirements formalization step using SySML and the virtual prototyping based on Petri Nets which takes place in the system design within the process of functional modeling, generating VHDL-AMS code to implement in FPGA.
  •  
27.
  • Mirez, J. L., et al. (författare)
  • Energy management of distributed resources in microgrids
  • 2014
  • Ingår i: 2014 IEEE 5th Colombian Workshop on Circuits and Systems, CWCAS 2014 - Conference Proceedings. - : Institute of Electrical and Electronics Engineers Inc.. - 9781479968381
  • Konferensbidrag (refereegranskat)abstract
    • The rapid increase in the integration of distributed resources such as distributed generation (DG), demand response (DR) and electricity storage (ES) requires management schemes to integrate distributed resources into low and medium electricity networks. Energy management represents a challenge for operation of electric grids when distributed resources are merged into the network. This paper address the energy management of distributes resources considering a complete characterization of them. The feasibility of those resources is considered into a microgrid model, so, the distributed resources are integrated through of a microgrid. This paper proposes the integration of distributed resources using a microgrid concept because there are relevant advantages of this model. The operational advantages are evident from the results. The results show how effectively different energy resources can be managed into the grid in the most efficient way. 
  •  
28.
  • Ordonez, C. A., et al. (författare)
  • Prony-based on-line oscillation detection with real PMU information
  • 2017
  • Ingår i: 2016 IEEE Colombian Conference on Robotics and Automation, CCRA 2016 - Conference Proceedings. - : Institute of Electrical and Electronics Engineers (IEEE). - 9781509037872
  • Konferensbidrag (refereegranskat)abstract
    • Wide-Area monitoring systems are a requirement in the current power systems in order to provide an appropriate monitoring, supervision and protection from undesired events. Electromechanical oscillations can provoke critical situations and affect the power transmission capability. This paper applies the Multi-Prony Analysis (MPA) to estimate the critical modes by using the tie-lines power measurements from Phasor Measuerement Unit (PMU)-data. The modes observation including an online sliding window give the frequency and damping variation allowing to detect and classify the range of the oscillation.
  •  
29.
  • Ospel, Johanna M., et al. (författare)
  • What is a Challenging Clot? : A DELPHI Consensus Statement from the CLOTS 7.0 Summit
  • 2023
  • Ingår i: Clinical Neuroradiology. - 1869-1439 .- 1869-1447. ; 33:4, s. 1007-1016
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Predicting a challenging clot when performing mechanical thrombectomy in acute stroke can be difficult. One reason for this difficulty is a lack of agreement on how to precisely define these clots. We explored the opinions of stroke thrombectomy and clot research experts regarding challenging clots, defined as difficult to recanalize clots by endovascular approaches, and clot/patient features that may be indicative of such clots. Methods: A modified DELPHI technique was used before and during the CLOTS 7.0 Summit, which included experts in thrombectomy and clot research from different specialties. The first round included open-ended questions and the second and final rounds each consisted of 30 closed-ended questions, 29 on various clinical and clot features, and 1 on number of passes before switching techniques. Consensus was defined as agreement ≥ 50%. Features with consensus and rated ≥ 3 out of 4 on the certainty scale were included in the definition of a challenging clot. Results: Three DELPHI rounds were performed. Panelists achieved consensus on 16/30 questions, of which 8 were rated 3 or 4 on the certainty scale, namely white-colored clots (mean certainty score 3.1), calcified clots under histology (3.7) and imaging (3.7), stiff clots (3.0), sticky/adherent clots (3.1), hard clots (3.1), difficult to pass clots (3.1) and clots that are resistant to pulling (3.0). Most panelists considered switching endovascular treatment (EVT) techniques after 2–3 unsuccessful attempts. Conclusion: This DELPHI consensus identified 8 distinct features of a challenging clot. The varying degree of certainty amongst the panelists emphasizes the need for more pragmatic studies to enable accurate a priori identification of such occlusions prior to EVT.
  •  
30.
  • Topic, D., et al. (författare)
  • Analysis of PV Systems and Charging Stations Integration into the Public Lighting Infrastructure
  • 2019
  • Ingår i: Proceedings of 2019 IEEE PES Innovative Smart Grid Technologies Europe, ISGT-Europe 2019. - : Institute of Electrical and Electronics Engineers (IEEE).
  • Konferensbidrag (refereegranskat)abstract
    • The utilization of Electric Vehicles (EV) is increasing every day. This implies an increasing usage of charging stations for the EV. Public lighting infrastructure during the day is not used and offers a huge potential for the integration of the charging stations. On the other hand, EVs are environmentally friendly if the energy for EVs comes from RESs. The goal of this paper is to investigate how PV systems can be used as a power supply for charging stations. In this way, one benefit is that EVs can be used as energy storage elements and allow better integration of the PV systems. A second benefit is that EV will be supplied by renewable energy. In this paper, a study on 5 scenarios is conducted. Based on simulation results in different scenarios, it can be concluded that PV system and charging stations can be easily integrated into the existing PLS.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-30 av 30

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy